Evofem Biosciences

๐Ÿ“ San Diego, United States๐Ÿ—“ Founded 2015๐Ÿ‘ฅ 56 employees๐Ÿ’ฐ Last funded Dec 2015
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Evofem Biosciences?
Evofem Biosciences has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Evofem Biosciences last raise funding?
The most recent investment in Evofem Biosciences recorded on gritt.io was in December 2015.
When was Evofem Biosciences founded?
Evofem Biosciences was founded in 2015.
What industry is Evofem Biosciences in?
Evofem Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Evofem Biosciences based?
Evofem Biosciences is headquartered in San Diego, United States.